Product Code: GVR-4-68040-195-1
Medical Device Design And Development Services Market Growth & Trends:
The global medical device design and development services market size is anticipated to reach USD 24.09 billion by 2030 and it is projected to grow at a CAGR of 13.2% from 2024 to 2030, according to a new report by Grand View Research, Inc.
Growing technological innovations facilitating medical product development through all phases, from initial concept generation to production manufacturing is anticipated to influence the market positively. The development of medical devices has observed significant advancements due to various technological innovations and techniques to develop products that meet the complex needs of the medical & scientific industries.
In addition, the medical devices industry has witnessed significant growth owing to presence of medical device Original Equipment Manufacturers (OEMs) that offers benefits with increased agility, low operational costs, and reduced time to market as well as high return of investment by outsourcing some of their operations. As, OEMs can transform their companies into strategic investments from cost centers. Furthermore, product design and development partners help in reducing time-to-market for a new device, thus speeding up the Return on Investment (ROI). Hence, this is expected to create demand for medical device design and development services.
Moreover, the medical device industry is witnessing competition where companies are opting for various marketing strategies to sustain competition. Besides, trends in medical device design and development industry are for variety of devices, drug delivery systems, therapeutic devices, and patient monitors that are becoming smaller in size, while improving features & performance. This factor has led to extensive R&D, product launches, competitive pricing, and mergers & acquisitions. Moreover, competition necessitates rapid product development and market entry.
In addition, the medical device design and development services are highly beneficial to companies as they helps them create innovative products that are not easy to replicate, allowing for market leadership. Also, the expertise provided by the outsourcing partners helps reduce costs and time for development, pilot testing, and market launching. Such factors are expected to drive the market over the estimated time period.
Medical Device Design And Development Services Market Report Highlights:
- Based on service, the designing & engineering segment dominated the market in 2023. The segment growth is driven by increasing high-quality user experience/interface and constantly changing requirements
- Based on the medical devices, the drug delivery devices segment held the largest market share in 2023, attributing to new features facilitating self-dosing and encouraging patient adherence. Drug delivery devices offer advantages to targeting diseased cells or tissues precisely, minimizing harmful effects on cells, making them suitable for a wide range of therapeutic applications
- Based on therapeutic area, the other segment held a market with the largest revenue share 70.0% in 2023. The segment is driven by the growing aging population and robust demand for medical devices in various therapeutic areas, contributing to its prominence in this field
- Based on the end-use, the medical device companies segment accounted for the largest share in 2023. High segment shares are majorly due to the growing medical device innovation and increasing overall healthcare expenditures, which are among some crucial factors driving the segment growth
- Asia Pacific dominated the market with a revenue share of 42.0% in 2023. The region has a strong R&D infrastructure and a robust medical device industry, which has contributed to the market growth
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Services
- 1.2.2. Devices
- 1.2.3. Therapeutic Area
- 1.2.4. End-use
- 1.2.5. Regional scope
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Devices outlook
- 2.2.2. Therapeutic Area outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Medical Device Design and Development Services Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Medical Device Design and Development Services Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
Chapter 4. Medical Device Design and Development Services Market: Services Estimates & Trend Analysis
- 4.1. Services Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Medical Device Design and Development Services Market by Services Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Designing & Engineering
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Machining
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Molding
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.4. Packaging
- 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Medical Device Design and Development Services Market: Devices Estimates & Trend Analysis
- 5.1. Devices Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Medical Device Design and Development Services Market by Devices Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Cardiovascular devices
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.2. Ventricular Assist Devices
- 5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.3. Total Artificial Hearts
- 5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.4. Pacemakers
- 5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.5. Implantable Cardioverter Defibrillators (ICDs)
- 5.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.6. Cardiac Loop Recorders
- 5.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.7. Holter Monitors
- 5.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.8. Event Monitors
- 5.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.9. ECMO Systems
- 5.4.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1.10. Consumables
- 5.4.1.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. POC diagnostic equipment
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.2. Blood glucose monitor
- 5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.3. Blood analyzer
- 5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.4. Blood pressure monitor
- 5.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.5. Pregnancy test kit
- 5.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.6. Infectious diseases testing
- 5.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.7. Hb1Ac testing
- 5.4.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.8. Coagulation testing Kit
- 5.4.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.9. Cardiac markers test
- 5.4.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.10. Thyroid stimulating hormone test
- 5.4.2.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2.11. Others
- 5.4.2.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Drug delivery devices
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.2. Autoinjectors
- 5.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.3. Infusion Pumps
- 5.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.4. Prefilled Syringes
- 5.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.5. Inhalers
- 5.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.6. Nebulizers
- 5.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.7. Nasal Spray
- 5.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.8. Intrauterine Devices (IUDs)
- 5.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3.9. Transdermal Patches
- 5.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Orthopedic devices
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4.2. Prosthetics
- 5.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4.3. Orthopedic Navigation Systems
- 5.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4.4. Others
- 5.4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Dental devices
- 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Surgical devices
- 5.4.6.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6.2. Surgical Robots
- 5.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6.3. Others
- 5.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7. Imagining devices
- 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7.2. X-Ray
- 5.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7.3. MRI Scanners
- 5.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7.4. Ultrasound
- 5.4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7.5. CT Scanners
- 5.4.7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7.6. Nuclear Imaging Scanners
- 5.4.7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8. Sleep & respiratory devices
- 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8.2. Positive Airway Pressure (PAP) Devices
- 5.4.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8.3. Ventilators
- 5.4.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8.4. Oxygen Concentrators
- 5.4.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8.5. Others
- 5.4.8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9. Ophthalmology devices
- 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9.2. Fundus Cameras
- 5.4.9.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9.3. Slit Lamps
- 5.4.9.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9.4. Optical Coherence Tomography
- 5.4.9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9.5. Corneal Topography Systems
- 5.4.9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9.6. Others
- 5.4.9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.10. Endoscopy
- 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.11. Diabetes care
- 5.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.12. Cochlear implants
- 5.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.12.2. Bionic Ear
- 5.4.12.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.12.3. Bionic Eye
- 5.4.12.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.13. Neurostimulators
- 5.4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.13.2. Spinal Cord Stimulators
- 5.4.13.3. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.13.4. Deep Brain Stimulators
- 5.4.13.5. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.13.6. Others
- 5.4.13.7. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.14. Others
- 5.4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Medical Device Design and Development Services Market: Therapeutic Area Estimates & Trend Analysis
- 6.1. Therapeutic Area Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Medical Device Design and Development Services Market by Therapeutic Area Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Cardiovascular
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Diagnostic
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Others
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Medical Device Design and Development Services Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. Global Medical Device Design and Development Services Market by End-use Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.4.1. Medical Device Companies
- 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Biotechnology Companies
- 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Medical Device Design and Development Services Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory scenario
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory scenario
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory scenario
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory scenario
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory scenario
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory scenario
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory scenario
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory scenario
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory scenario
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory scenario
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory scenario
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory scenario
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory scenario
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory scenario
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory scenario
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory scenario
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory scenario
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.2. Mexico
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory scenario
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 8.8.3. Argentina
- 8.8.3.1. Key country dynamics
- 8.8.3.2. Regulatory scenario
- 8.8.3.3. Competitive scenario
- 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9. MEA
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory scenario
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory scenario
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory scenario
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory scenario
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2023
- 9.3.4. Ximedica
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Product benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. DeviceLAb
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Product benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. Jabil, Inc.
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Product benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Flex Ltd
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Product benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Plexus Corp
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Product benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. Nordson Medical
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Product benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. Celestica, Inc.
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Product benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. Starfish Medical
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Product benchmarking
- 9.3.11.4. Strategic initiatives
- 9.3.12. Planet Innovation
- 9.3.12.1. Company overview
- 9.3.12.2. Financial performance
- 9.3.12.3. Product benchmarking
- 9.3.12.4. Strategic initiatives
- 9.3.13. Donatelle
- 9.3.13.1. Company overview
- 9.3.13.2. Financial performance
- 9.3.13.3. Product benchmarking
- 9.3.13.4. Strategic initiatives
- 9.3.14. Cambridge Design Partnership
- 9.3.14.1. Company overview
- 9.3.14.2. Financial performance
- 9.3.14.3. Product benchmarking
- 9.3.14.4. Strategic initiatives
- 9.3.15. Aran Biomedical
- 9.3.15.1. Company overview
- 9.3.15.2. Financial performance
- 9.3.15.3. Product benchmarking
- 9.3.15.4. Strategic initiatives
- 9.3.16. Cirtec
- 9.3.16.1. Company overview
- 9.3.16.2. Financial performance
- 9.3.16.3. Product benchmarking
- 9.3.16.4. Strategic initiatives
- 9.4. Participant Categorization
- 9.5. Market Leaders
- 9.5.1. Medical Device Design and Development Services Market Share Analysis, 2023
- 9.6. Strategy Mapping
- 9.6.1. Service Launches/Upgrades
- 9.6.2. Mergers/Acquisitions/Joint Ventures Merger/
- 9.6.3. Partnerships/Agreements
- 9.6.4. Expansions
- 9.6.5. Others
- 9.7. Market Position Analysis, 2022/2023 (Heat Map Analysis)
Chapter 10. Key Takeaways